Patent · US Active

Compounds and methods for treating pain

US11053307B2 · kind B2 · utility

1Cited by
8References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 17, 2019
Grant dateJul 6, 2021
Priority date
Expiry dateSep 17, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/35
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This disclosure provides compositions and methods for controlling pain. In particular the disclosure provides a method for controlling pain comprising co-administration of an NGF antagonist and a TNFα antagonist. The NGF antagonist and the TNFα antagonist can be separate molecules or part of a multifunctional polypeptide, e.g., a multispecific binding molecule that comprises an NGF antagonist domain and a TNFα antagonist domain. This disclosure also provides multifunctional polypeptides, e.g., multispecific binding molecules, comprising an NGF antagonist domain, and a TNFα antagonist domain. The method provides improved pain control. Administration of an NGF antagonist and a TNFα antagonist as provided herein can control pain in the subject more effectively than an equivalent amount of the NGF antagonist or the TNFα antagonist administered alone.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.